scispace - formally typeset
M

Miguel A. Salinero-Fort

Researcher at Hospital Universitario La Paz

Publications -  68
Citations -  1185

Miguel A. Salinero-Fort is an academic researcher from Hospital Universitario La Paz. The author has contributed to research in topics: Population & Type 2 Diabetes Mellitus. The author has an hindex of 20, co-authored 58 publications receiving 960 citations. Previous affiliations of Miguel A. Salinero-Fort include Carlos III Health Institute & Carlos III Hospital.

Papers
More filters
Journal ArticleDOI

Prevalence of adherence to treatment in homebound elderly people in primary health care: a descriptive, cross-sectional, multicentre study.

TL;DR: Poor therapeutic adherence in homebound elderly patients receiving polypharmacy is a serious problem affecting one of every three individuals concerned, and is directly related to caregiver burden, regardless of age, sex, cognitive status or number of drugs administered.
Journal ArticleDOI

Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus

TL;DR: PRECEDE health education model is a useful method in the overall treatment in patients with type 2 diabetes, which contributes to decrease glycated hemoglobin A1c and SBP levels and increase the compliance in all the control criteria, except for LDL cholesterol.
Journal ArticleDOI

Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study) : results from the MADIABETES cohort.

TL;DR: Depression is very prevalent among patients with type 2 diabetes mellitus and is associated with several key diabetes-related outcomes and the results suggest that previous mental status, self-reported health status, gender and several diabetes- related complications are associated with differences in the degree of depression.
Journal ArticleDOI

Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study.

TL;DR: This is the first study to demonstrate an association between aspirin use and diabetic retinopathy risk in a well-defined cohort of patients with Type 2 Diabetes Mellitus at low risk of cardiovascular events.